InO plays a crucial role in the treatment of acute lymphoblastic leukemia (ALL) by targeting cancer cells that abnormally express CD22, thereby inducing cell cycle arrest and apoptosis [43]. The gene discussed is CD22; the disease is acute lymphoblastic leukemia.